^
Association details:
Evidence:
Evidence Level:
Resistant: D – Preclinical
New
Source:
Title:

Differential Sensitivity of ERBB2 Kinase Domain Mutations towards Lapatinib

Excerpt:
...ERBB2-L755S (IC50>2 µM), ERBB2-L755P (IC50>1.5 µM)...caused strong lapatinib resistance.
DOI:
10.1371/journal.pone.0026760